Skip to main content
Journal cover image

Phase I trial of Temodar plus O-6-benzylguanine 5-day regimen for patients with progressive glioblastoma multiforme

Publication ,  Conference
Quinn, JA; Desjardins, A; Rich, JN; Vredenburgh, JJ; Reardon, DA; Gururangan, S; Sathornsumetee, S; Walker, A; Lavin, KN; Birch, R ...
Published in: NEURO-ONCOLOGY
October 1, 2006

Duke Scholars

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2006

Volume

8

Issue

4

Start / End Page

450 / 450

Location

Vienna, AUSTRIA

Publisher

DUKE UNIV PRESS

Conference Name

7th Congress of the European-Association-for-Neuro-Oncology (EANO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Quinn, J. A., Desjardins, A., Rich, J. N., Vredenburgh, J. J., Reardon, D. A., Gururangan, S., … Friedman, H. S. (2006). Phase I trial of Temodar plus O-6-benzylguanine 5-day regimen for patients with progressive glioblastoma multiforme. In NEURO-ONCOLOGY (Vol. 8, pp. 450–450). Vienna, AUSTRIA: DUKE UNIV PRESS.
Quinn, J. A., A. Desjardins, J. N. Rich, J. J. Vredenburgh, D. A. Reardon, S. Gururangan, S. Sathornsumetee, et al. “Phase I trial of Temodar plus O-6-benzylguanine 5-day regimen for patients with progressive glioblastoma multiforme.” In NEURO-ONCOLOGY, 8:450–450. DUKE UNIV PRESS, 2006.
Quinn JA, Desjardins A, Rich JN, Vredenburgh JJ, Reardon DA, Gururangan S, et al. Phase I trial of Temodar plus O-6-benzylguanine 5-day regimen for patients with progressive glioblastoma multiforme. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2006. p. 450–450.
Quinn, J. A., et al. “Phase I trial of Temodar plus O-6-benzylguanine 5-day regimen for patients with progressive glioblastoma multiforme.” NEURO-ONCOLOGY, vol. 8, no. 4, DUKE UNIV PRESS, 2006, pp. 450–450.
Quinn JA, Desjardins A, Rich JN, Vredenburgh JJ, Reardon DA, Gururangan S, Sathornsumetee S, Walker A, Lavin KN, Birch R, Friedman AH, Friedman HS. Phase I trial of Temodar plus O-6-benzylguanine 5-day regimen for patients with progressive glioblastoma multiforme. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2006. p. 450–450.
Journal cover image

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2006

Volume

8

Issue

4

Start / End Page

450 / 450

Location

Vienna, AUSTRIA

Publisher

DUKE UNIV PRESS

Conference Name

7th Congress of the European-Association-for-Neuro-Oncology (EANO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences